Crunch Time For Idorsia Insomnia Therapy As Reviews Begin

Daridorexant Is Swiss Company's First Drug

The US FDA has accepted the Swiss biotech's "huge" NDA file for daridorexant which the company hopes will be more successful on the insomnia market than other DORA sleep treatments such as Merck & Co's Belsomra.

clozel
CEO Jean-Paul Clozel • Source: Idorsia

More from New Products

More from Scrip